June 11th 2025. Ron Lanton, Partner, Lanton Law, discusses the constitutional and statutory challenges facing the President’s use of executive orders to implement international drug …

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.

Jun 3, 2025 · Combination Therapy Preserves Muscle Mass: Regeneron’s semaglutide plus trevogrumab combo significantly preserved lean muscle mass in patients with obesity, …

Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in …

4 days ago · Results from the Phase III CORALreef HeFH and CORALreef AddOn trials show that enlicitide decanoate, Merck’s investigational oral PCSK9 inhibitor for adults with …

May 12, 2025 · On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for pharmaceutical drug prices. On the social …

Mar 11, 2025 · The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics,” is a game …

May 14, 2025 · 3 Key Takeaways . GSK has acquired efimosfermin alfa, a Phase III-ready FGF21 analog from Boston Pharmaceuticals, in a deal valued at up to $2 billion, expanding its …

May 5, 2025 · Merck announced that construction has begun on a new $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Del. According to the company, the new site …

Feb 13, 2025 · The pharmacy benefits industry is gearing up for significant change in the coming years. Projections point to a dramatic surge to $875 billion by 2026, constituting 15.4% of the …